Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into the regulation and signaling landscape of cardiotrophin-like cytokine factor 1 (CLCF1).

Biochimica et biophysica acta. Molecular cell research·2026
Same author

ARF6 controls VSMC phenotypic switching upon lipid stimulation to promote inflammatory signaling contributing to the progression of atherosclerosis.

The Journal of biological chemistry·2026
Same author

Cardiotrophin-like cytokine factor 1 forms a complex with IL12/IL23p40.

Scientific reports·2025
Same author

CLCF1 promotes IL12Rβ2 proteolysis and limits Th1 differentiation.

Cytokine·2025
Same author

A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcome.

EMBO molecular medicine·2025
Same author

DEMOGRAPHIC PROFILE, SUBSTANCE USE TRENDS AND ASSOCIATED PSYCHOTIC DISORDERS AMONG VETERANS WITH MENTAL HEALTH CONDITIONS: A RETROSPECTIVE COHORT STUDY OF US VETERANS.

ASEAN journal of psychiatry·2025

Related Experiment Video

Updated: May 19, 2026

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells
11:01

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells

Published on: December 17, 2015

IL-6 activates STAT5 in T cells.

Aurélie Jeanne Tormo1, Marie-Claude Letellier, Mukut Sharma

  • 1Département de Pharmacologie, Université de Montréal, Montreal QC, Canada.

Cytokine
|August 3, 2012
PubMed
Summary

Interleukin-6 (IL-6) activates STAT5 in T cells, creating a feedback loop that balances pro-inflammatory and regulatory cell differentiation. This finding suggests new therapeutic targets for IL-6-related inflammatory diseases.

More Related Videos

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Related Experiment Videos

Last Updated: May 19, 2026

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells
11:01

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells

Published on: December 17, 2015

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Interleukin-6 (IL-6) is a key cytokine regulating CD4 T cell differentiation.
  • IL-6 promotes T helper 1, T helper 17, and T follicular helper cells while inhibiting regulatory T cells.
  • The JAK/STAT3 pathway is primarily implicated in IL-6-driven T helper cell differentiation.

Purpose of the Study:

  • To investigate IL-6-induced STAT1, STAT3, and STAT5 activation in mouse immune cells.
  • To determine the effect of IL-6 on the expression of cytokine-inducible SH2-containing protein (CIS) mRNA.
  • To elucidate the role of STAT5 in modulating T cell differentiation in response to IL-6.

Main Methods:

  • Flow cytometry (phosflow) was used to analyze STAT phosphorylation.
  • Mouse mononuclear cells were stimulated with IL-6.
  • mRNA levels for CIS were quantified.

Main Results:

  • IL-6 induced STAT5 activation in CD4 T cells, CD8 T cells, and NK cells.
  • STAT5 activation by IL-6 was transient and required higher concentrations than STAT3 activation.
  • IL-6 stimulation led to increased CIS synthesis, a STAT5-regulated gene.

Conclusions:

  • IL-6 can activate a STAT5-mediated negative feedback loop in CD4 T cells, balancing pro-inflammatory (STAT3) and regulatory (STAT5) T cell populations.
  • STAT5 activation may influence T helper cell differentiation by affecting TGF-β stability and production.
  • Targeting STAT3 or enhancing STAT5 activity could offer therapeutic benefits in IL-6-associated inflammatory conditions.